✦ LIBER ✦

Spotlight on Amoxicillin/Clavulanic Acid 2000mg/125mg Extended Release (XR) in Respiratory Tract Infections in Adults

✍ Scribed by Paul L. McCormack, Gillian M. Keating

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amoxicillin/Clavulanic Acid 2000mg/125mg

✍ Paul L. McCormack, Gillian M. Keating 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 269 KB

Roxithromycin 150 mg b.i.d. versus amoxy

✍ N. C. Karalus; J. E. Garrett; S. D. R. Lang; R. A. Leng; G. N. Kostalas; R. T. M 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 1024 KB

Comparative in vitro activity of a pharm

✍ Laura M. Koeth; Michael R. Jacobs; Caryn E. Good; Saralee Bajaksouzian; Anne Win 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Efficacy of amoxicillin/clavulanic acid

✍ M. Arteagoitia; G. Santamaria; E. Ramos; L. Barbier; J. Alvarez; J. Martín; J. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 96 KB

A short (3-day) course of azithromycin t

✍ I.M Hoepelman; M.J Möllers; M.H van Schie; A.P.M Greefhorst; N.J.J Schlösser; E. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 80 KB